C3 and focal segmental glomerulosclerosis: An observational retrospective cohort study investigated 70 patients previously diagnosed with primary FSGS proven through renal biopsy and 39 healthy subjects in the control group by measuring plasma and urine levels of C3a, C5a, and soluble C5b-9.